NSE · AI Signal & Stock Analysis · Bearish
As of Nov 13 2026, 6:15 AM, AkshayaAI's signal for AKUMS is Bearish ↓ (mild move); technical trend down-trend; trading at ₹749.90 (-2.59% today); neutral (RSI 51). What changed: the technical trend turned down-trend (was Raise) on 12 Nov 2026.
Data as of Nov 13 2026, 6:15 AM. Informational analytics only — not investment advice.
Instant, data-backed answers — free to try.
| AI signal | Bearish ↓ · Mild move |
|---|---|
| Technical trend | Down-trend (since 2026-11-12) |
| Price | ₹749.90 |
| Change today | -2.59% |
| RSI (14) | 50.60 |
| Relative volume | 0.52 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹11,346 Cr |
| P/E | 31.19 |
| Cap category | Mid Cap |
| 52-week high | -8.9% away |
| 52-week low | +82.0% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - Specialty & Generic |
As of Nov 13 2026, 6:15 AM, AkshayaAI's signal for AKUMS (Akums Drugs and Pharmaceuticals Limited) is Bearish with a mild move, and its technical trend is down-trend. The composite score and full factor breakdown are available to signed-in members.
AKUMS's RSI is neutral (RSI 51). A reading above 70 is typically overbought and below 30 oversold.
AKUMS is trading about 9% below its 52-week high and 82% above its 52-week low as of Nov 13 2026, 6:15 AM.
AKUMS's market capitalisation is ₹11,346 Cr as of Nov 13 2026, 6:15 AM.
AKUMS is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for AKUMS — not personalised investment advice. Always do your own research.
AARTIPHARM · ABBOTINDIA · AJANTPHARM · ALIVUS · ALKEM · APLLTD
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Nov 13 2026, 6:15 AM and may not reflect real-time prices. Always do your own research. How these signals work →